HALO logo
halo search icon
Biofrontera, Inc.

US$0.81

Price Change Indicator
0.0008 (0.099%)
Biofrontera, Inc.
BFRI · NAS

Biofrontera, Inc.

Start Trading BFRI for Free

US$0.81

Price Arrow0.0008 (0.099%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BullishHALO AllHALO Consensus ValueRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Biofrontera, Inc. Overview

BFRI Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BFRI

icon

Website

Biofrontera, Inc.

icon

Telephone

1.781.245.1325

icon

Address

Suite 330, 120 Presidnetial Way, Woburn, MA 01801

Description

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

BFRI Price Chart

Key Stats

Market Cap

US$10.32M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.54 - 1.19

Trade Value (12mth)

US$53,958.00

1 week

0.75%

1 month

-26.06%

YTD

11.17%

1 year

24.75%

All time high

292.60

Key Fundamentals

EPS 3 yr Growth

71.10%

EBITDA Margin

-19.90%

Operating Cashflow

-$13m

Free Cash Flow Return

-106.40%

ROIC

-83.90%

Interest Coverage

-18.30

Quick Ratio

1.40

Other Data

Shares Outstanding (Fully Diluted)

12m

HALO Sector

Healthcare

Next Company Report Date

19-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BFRI Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
15 May 26
14 May 26
14 May 26

BFRI Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-13.02-3.22-1.04locklocklock
EPS (Fully Diluted)
 $locklocklocklock-13.02-3.22-1.04locklocklock
Growth
 %locklocklocklock-2,050.475.367.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Biofrontera, Inc. (BFRI:NAS)?
Halo FAQ
The current share price of Biofrontera, Inc. (BFRI:NAS) is USD$0.81.
What is the 52-week high share price for Biofrontera, Inc. (BFRI:NAS)?
Halo FAQ
The 52-week high share price for Biofrontera, Inc. (BFRI:NAS) is USD$1.19.
What is the 52-week low share price for Biofrontera, Inc. (BFRI:NAS)?
Halo FAQ
The 52-week low share price for Biofrontera, Inc. (BFRI:NAS) is USD$0.54.
What is the dividend yield for Biofrontera, Inc. (BFRI:NAS)?
Halo FAQ
Biofrontera, Inc. (BFRI:NAS) does not pay a dividend.
What was Biofrontera, Inc. (BFRI:NAS) last dividend payment?
Halo FAQ
Biofrontera, Inc. (BFRI:NAS) does not pay a dividend.
What is the franking level for Biofrontera, Inc. (BFRI:NAS)?
Halo FAQ
Biofrontera, Inc. (BFRI:NAS) has a franking level of 0.00%.
In which sector is Biofrontera, Inc. (BFRI:NAS) classified?
Halo FAQ
Biofrontera, Inc. (BFRI:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial